Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...
Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...